| Literature DB >> 30513141 |
Xiuhua Bozarth1,2, Jennifer N Dines3,4, Qian Cong5, Ghayda M Mirzaa2,3, Kimberly Foss6, J Lawrence Merritt3, Jenny Thies6, Heather C Mefford3, Edward Novotny1,2.
Abstract
CACNA1C (NM_000719.6) encodes an L-type calcium voltage-gated calcium channel (Cav 1.2), and pathogenic variants have been associated with two distinct clinical entities: Timothy syndrome and Brugada syndrome. Thus far, CACNA1C has not been reported as a gene associated with epileptic encephalopathy and is less commonly associated with epilepsy. We report three individuals from two families with variants in CACNA1C. Patient 1 presented with neonatal onset epileptic encephalopathy (NOEE) and was found to have a de novo missense variant in CACNA1C (c.4087G>A (p.V1363M)) on exome sequencing. In Family 2, Patient 2 presented with congenital cardiac anomalies and cardiomyopathy and was found to have a paternally inherited splice site variant, c.3717+1_3717+2insA, on a cardiomyopathy panel. Her father, Patient 3, presented with learning difficulties, late-onset epilepsy, and congenital cardiac anomalies. Family 2 highlights variable expressivity seen within a family. This case series expands the clinical and molecular phenotype of CACNA1C-related disorders and highlights the need to include CACNA1C on epilepsy gene panels.Entities:
Keywords: CACNA1C; electroencephalogram; epileptic encephalopathy; exome sequencing; neonatal onset epileptic encephalopathy
Mesh:
Substances:
Year: 2018 PMID: 30513141 PMCID: PMC6312477 DOI: 10.1002/ajmg.a.40657
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802